It is a chemicals public limited company based in Chennai, Tamil Nadu, India, established in 1996.
1996 | Chennai, Tamil Nadu, India | AmalgamatedGrandix Pharmaceuticals Limited, a amalgamated public limited company, was established on 04 April 1996 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical chemical within the chemicals sector, it holds CIN: U24231TN1996PLC035068. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.64 M.
Its leadership includes Venkataraman Subramanian Iyer (Additional Director), Thirukandalam Srinivasan Rangan (Additional Director), Arun Kumar Pillai (Director). Past directors included Malathi Ramamurthy, Sundaram Nadar Arulrhaj, Ravi Seth. Its latest AGM occurred on 19 June 2009, with the balance sheet filed on 31 December 2008. It is based at 42, Loganathan Nagar100 Ft Road, Choolaimedu, Chennai, Tamil Nadu, 600094.
U24231TN1996PLC035068
035068
04 April 1996
₹6.00 Cr
₹4.64 M
Roc Chennai
Unlisted
Amalgamated
Explore comprehensive insights into Grandix Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkataraman Subramanian Iyer | Additional Director | 16 Mar 2009 | Current |
| Thirukandalam Srinivasan Rangan | Additional Director | 16 Mar 2009 | Current |
| Arun Kumar Pillai | Director | 20 Jan 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jun 2007 | Past |
| Pramod Abcsdd | Director | 02 Jun 2007 | Past |
| Pramod Abcsdd | Director | 16 Mar 2009 | Past |
| Pramod Abcsdd | Director | 02 Jun 2007 | Past |
| Pramod Abcsdd | Director | 02 Jun 2007 | Past |
| Pramod Abcsdd | Managing Director | 09 Jun 2007 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Grandix Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Grandix Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Grandix Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Grandix Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grandix Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Grandix Pharmaceuticals Limited last Annual general meeting of members was held on 19 Jun 2009 as per latest MCA records. was recorded as a recent event.
Venkataraman Subramanian Iyer was appointed as a Additional Director was appointed as a Additional Director on 16 Mar 2009 & has been associated with this company since 16 years 8 months . was recorded as a recent event.
The activity Thirukandalam Srinivasan Rangan was appointed as a Additional Director was appointed as a Additional Director on 16 Mar 2009 & has been associated with this company since 16 years 8 months . was completed.
Progress on Grandix Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Dec 2008 with Roc Chennai. was documented.
The activity Arun Kumar Pillai was appointed as a Director was appointed as a Director on 20 Jan 2007 & has been associated with this company since 18 years 10 months . was completed.
Grandix Pharmaceuticals Limited was registered on 04 Apr 1996 with Roc Chennai & aged 29 years 7 months as per MCA records. was recorded as a recent event.
The CIN of Grandix Pharmaceuticals Limited is U24231TN1996PLC035068.
Grandix Pharmaceuticals Limited is headquartered at 42, Loganathan Nagar100 Ft Road, Choolaimedu, Chennai, Tamil Nadu, 600094.
Grandix Pharmaceuticals Limited was incorporated on 04 April 1996.
The current directors of Grandix Pharmaceuticals Limited are
The primary industry of Grandix Pharmaceuticals Limited is Chemicals.
Grandix Pharmaceuticals Limited is unlisted.
The authorized capital of Grandix Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹4.64 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX